Alluvi tirzepatide appears to have emerged as a promising therapeutic candidate for the treatment of metabolic conditions. This exploratory evaluation assessed the efficacy and safety of tirzepatide 40mg in in vivo models of type 2 diabetes. The studies demonstrated that tirzepatide 40mg significantly enhanced glycemic regulation and decreased insu